There’s limited scientific evidence directly linking semaglutide use to vitamin B12 deficiency or recommending routine vitamin B12 supplementation for people taking semaglutide. Semaglutide is ...

WEDNESDAY, April 2, 2025 (HealthDay News) -- For patients with symptomatic peripheral artery disease and type 2 diabetes, semaglutide use is associated with increased walking distance, according ...

All were randomly assigned to receive semaglutide (1 mg) or placebo for one year (52 weeks). Researchers assessed maximal walking distance—the maximum distance that patients were able to walk on ...

offering patients an innovative and effective therapeutic intervention. The observed impact of oral semaglutide on cardiovascular outcomes underscores its potential to address a critical unmet ...